If you've struggled with weight for years, tried every diet, and felt like your body was fighting against you - you weren't imagining it. Obesity is a complex metabolic disease, not a character flaw. And now, peptide medications are offering something many people have never experienced: their biology working with them instead of against them.
Written by — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Here's the frustrating truth: when you lose weight through dieting alone, your body interprets it as a threat. Your metabolism slows down, hunger hormones increase, and fullness hormones decrease. You're not just fighting willpower - you're fighting metabolic adaptation.
Your brain has a 'set point' it defends vigorously. When you drop below it, everything in your biology conspires to push you back up. Ghrelin (the hunger hormone) increases. Leptin (the fullness hormone) decreases. Your metabolic rate drops. Food becomes more rewarding. This isn't weakness - it's evolution.
format_quoteYour biology was designed for scarcity, not abundance.
This is where peptide medications change the game. They work on the hormonal systems that regulate appetite and metabolism, essentially resetting your body's 'thermostat' so it stops fighting against you.
track_changes
FDA Approved 2021 (Wegovy for weight management)
Semaglutide (Wegovy)
The Breakthrough
A GLP-1 receptor agonist FDA-approved for chronic weight management. The same molecule as Ozempic, but at higher doses specifically approved for weight loss.
Its role
Turning down your body's 'hunger thermostat' while turning up the 'satisfied' signal
Typical range
0.25 mg to 2.4 mg weekly
The bottom line
Semaglutide for weight loss represents the most significant advance in obesity treatment in decades. Clinical trials show average weight loss of 15% of body weight - results previously only achievable with surgery.
layers
FDA Approved 2023 (Zepbound for weight management)
Tirzepatide (Zepbound)
The Dual-Action Leader
The first dual GIP/GLP-1 receptor agonist FDA-approved for weight management. Activates two hormonal pathways for enhanced results.
Its role
Two keys working together to unlock weight loss potential
Typical range
2.5 mg to 15 mg weekly
The bottom line
Tirzepatide produces even greater weight loss than semaglutide in head-to-head comparisons. Clinical trials show average weight loss of 20%+ - approaching surgical results without surgery.
schedule
FDA Approved 2014 (Saxenda for weight management)
Liraglutide (Saxenda)
The Daily Pioneer
A GLP-1 receptor agonist requiring daily injection. Was the first GLP-1 medication FDA-approved specifically for weight management.
Its role
Daily reinforcement of your body's satiety signals
Typical range
0.6 mg to 3.0 mg daily
The bottom line
While newer medications produce more weight loss, liraglutide remains a solid option with extensive safety data. Some patients prefer the flexibility of daily dosing for dose adjustments.
compress
Approved 2010
Tesamorelin
The Visceral Fat Fighter
A growth hormone-releasing hormone (GHRH) analog FDA-approved for HIV-associated lipodystrophy, studied for visceral fat reduction.
Its role
Targeting the dangerous fat around your organs specifically
Typical range
0.1-0.2 mg daily
The bottom line
Tesamorelin specifically reduces visceral (belly) fat - the metabolically dangerous fat around organs. While FDA-approved for HIV lipodystrophy, it's studied for general visceral adiposity.
A combination of a growth hormone-releasing hormone (GHRH) analog and a growth hormone-releasing peptide (GHRP) used in clinical research and anti-aging medicine.
Its role
Encouraging your body to produce more of its own growth hormone
Typical range
100 mcg twice daily (typical combined protocol)
The bottom line
This combination stimulates natural growth hormone release, which can improve body composition by promoting fat loss and lean mass preservation. Popular in anti-aging medicine but not FDA-approved for weight loss.
content_cut
Investigational (Phase II/III trials completed but not FDA-approved)
AOD-9604
The GH Fragment
A modified fragment of human growth hormone (amino acids 177-191) that may have fat-burning properties without the full effects of growth hormone.
Its role
Just the fat-burning piece of growth hormone, isolated
Typical range
250-500 mcg daily
The bottom line
AOD-9604 was developed as an anti-obesity agent and showed promise in early trials, though development stalled. It's available as a research peptide and is used in some clinical settings.
Each peptide targets a different aspect of the condition. Together, they create a comprehensive approach.
01track_changesSemaglutide (Wegovy)The BreakthroughTurning down your body's 'hunger thermostat' while turning up the 'satisfied' signal
02layersTirzepatide (Zepbound)The Dual-Action LeaderTwo keys working together to unlock weight loss potential
03scheduleLiraglutide (Saxenda)The Daily PioneerDaily reinforcement of your body's satiety signals
04compressTesamorelinThe Visceral Fat FighterTargeting the dangerous fat around your organs specifically
05scienceCJC-1295/IpamorelinThe Research CombinationEncouraging your body to produce more of its own growth hormone
06content_cutAOD-9604The GH FragmentJust the fat-burning piece of growth hormone, isolated
4 angles of attack
psychology
Appetite Regulation
GLP-1 peptides work in the brain to reduce hunger and increase satisfaction from food
timer
Gut Signaling
Slowing stomach emptying and enhancing gut hormone release helps you feel full longer
local_fire_department
Metabolic Effects
Improved insulin sensitivity and glucose metabolism support fat burning
fitness_center
Body Composition
GH-related peptides may help preserve muscle while losing fat
An honest breakdown based on research and clinical reports.
schedule
Phase 1 of 5
Week 1-4
The Adjustment Phase
What's happening inside
Starting on low doses that will gradually increase. Your body is adjusting to the medication. Appetite changes are beginning but weight loss is usually modest.
What you might notice
Appetite reduction - not feeling as hungry
Getting full faster at meals
Possible GI side effects: nausea, constipation, sometimes diarrhea
Weight loss of 2-5 pounds typical (some is water weight)
Food starting to seem less interesting or appealing
warning Watch for
Nausea is most common early on. Eat smaller meals, avoid greasy foods, stay hydrated. This usually improves as your body adjusts.
Realistic expectations
Focus on tolerating the medication and adjusting eating patterns, not dramatic weight loss.
trending_up
Phase 2 of 5
Month 2-3
Building Momentum
What's happening inside
On higher doses now. Weight loss is becoming consistent. New eating patterns are becoming normal. GI side effects typically improving.
What you might notice
Consistent weight loss of 1-2+ pounds per week
'Food noise' significantly reduced - less thinking about food
Portions that satisfy you are much smaller
Energy often improving as weight drops
Clothes starting to fit differently
Cravings for unhealthy foods diminishing
warning Watch for
Some people experience transient hair thinning during rapid weight loss (telogen effluvium). This is temporary and related to the weight loss itself, not the medication specifically.
Realistic expectations
You're in the active weight loss phase. This is where you'll see most of your progress.
auto_awesome
Phase 3 of 5
Month 4-6
Significant Progress
What's happening inside
On maintenance dose or approaching it. Substantial weight loss achieved. Metabolic improvements measurable on lab work.
What you might notice
10-15%+ body weight lost (often more with tirzepatide)
New relationship with food - eating for fuel, not comfort
Significant improvements in blood pressure, blood sugar, cholesterol
Energy and mobility notably improved
May need smaller clothing sizes
Joint pain often reduced
warning Watch for
This is when people sometimes get complacent. Continue healthy habits - the medication works best as part of a lifestyle approach.
Realistic expectations
Major progress achieved. Focus shifts to maintaining new habits and continuing gradual improvement.
check_circle
Phase 4 of 5
Month 6-12
Consolidation
What's happening inside
Weight loss may slow as you approach a new stable weight. Body composition continues improving. Focus shifts to maintenance.
What you might notice
Weight loss rate naturally slows (this is normal)
Total weight loss of 15-25%+ achievable
Body composition improving even if scale stabilizes
Metabolic health markers often normalized
New 'set point' being established
Sustainable eating patterns solidified
warning Watch for
Weight loss plateaus are normal and don't mean the medication stopped working. Your body is finding a new equilibrium.
Realistic expectations
You're approaching your new maintenance weight. The medication is helping you stay there.
favorite
Phase 5 of 5
12+ Months
Long-Term Maintenance
What's happening inside
The goal is maintaining weight loss and metabolic improvements long-term. Cardiovascular benefits continue to accumulate.
What you might notice
Weight maintained at significantly lower level
Reduced risk of heart disease, stroke, and diabetes
Improved quality of life sustained
Some patients may reduce dose while maintaining benefits
Ongoing medication typically needed to prevent regain
Realistic expectations
This is maintenance phase. The medication continues working to help you maintain your new, healthier weight.
General guidelines based on research literature and clinical reports. Work with a healthcare provider experienced in peptide therapy to customize for your situation.
warningImportant: These are general guidelines. Don't self-prescribe based on internet articles. Work with a qualified healthcare provider.
Semaglutide (Wegovy) · typical range
0.25mg
to 2.4 mg weekly
Common protocols
medicationMonth 1: 0.25 mg weekly
medicationMonth 2: 0.5 mg weekly
medicationMonth 3: 1.0 mg weekly
medicationMonth 4: 1.7 mg weekly
medicationMonth 5+: 2.4 mg weekly (maintenance)
Timing considerations
scheduleOnce weekly on the same day
scheduleAny time of day, with or without food
scheduleSlow dose escalation minimizes GI side effects
scheduleInjection sites: abdomen, thigh, or upper arm
repeat Cycling
Continuous long-term use recommended for weight maintenance
Tirzepatide (Zepbound) · typical range
2.5mg
to 15 mg weekly
Common protocols
medicationWeeks 1-4: 2.5 mg weekly
medicationWeeks 5-8: 5 mg weekly
medicationWeeks 9-12: 7.5 mg weekly
medicationWeeks 13-16: 10 mg weekly
medicationWeeks 17-20: 12.5 mg weekly
medicationWeeks 21+: 15 mg weekly (maximum)
Timing considerations
scheduleOnce weekly on the same day
scheduleAny time of day, with or without food
scheduleSlower escalation if GI side effects are problematic
scheduleInjection sites: abdomen, thigh, or upper arm
repeat Cycling
Continuous long-term use
Liraglutide (Saxenda) · typical range
0.6mg
to 3.0 mg daily
Common protocols
medicationWeek 1: 0.6 mg daily
medicationWeek 2: 1.2 mg daily
medicationWeek 3: 1.8 mg daily
medicationWeek 4: 2.4 mg daily
medicationWeek 5+: 3.0 mg daily (maintenance)
Timing considerations
scheduleOnce daily at any time
scheduleSame time each day for consistency
scheduleWith or without food
scheduleInjection sites: abdomen, thigh, or upper arm
Some people find sleep improves on GLP-1 medications
What to keep in mind.
warning
Ongoing Treatment
Most people need to continue medication to maintain weight loss. Studies show significant weight regain when GLP-1 medications are stopped. Think of it like blood pressure medication - treating an ongoing condition, not a short-term fix.
payments
Cost and Access
These medications are expensive ($1,000+/month without insurance) and often not covered by insurance for weight loss. Availability can be limited due to high demand. Discuss cost and coverage options with your healthcare provider.
stethoscope
Side Effects Are Common
Most people experience some GI side effects, especially early on. Nausea, constipation, and diarrhea are common. These usually improve but can be significant. Some people can't tolerate these medications.
This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before starting any new treatment.
Peptide medications for weight loss represent a genuine breakthrough. For the first time, many people are experiencing what it's like when their biology isn't fighting against them constantly. These aren't 'cheating' - they're treating a complex metabolic disease with effective medicine.
Work with healthcare providers experienced in obesity medicine. The medication is powerful, but combining it with lifestyle changes maximizes results and helps you build habits that support long-term success.
0.25 mg to 2.4 mg weeklySemaglutide (Wegovy) · typical range in this guide